HomeGeneticsCondition16p11.2 deletion syndrome
Back to Condition
16p11.2 deletion syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

16p11.2 Deletion Syndrome

16p11.2 deletion syndrome is a chromosomal disorder caused by a missing segment on chromosome 16, typically resulting in developmental delay, intellectual disability, and features of autism spectrum disorders, with highly variable symptoms.

Overview

16p11.2 deletion syndrome is a disorder caused by a deletion of a small piece of chromosome 16. The deletion occurs near the middle of the chromosome at a location designated p11.2.

People with 16p11.2 deletion syndrome usually have developmental delay and intellectual disability. Most also have at least some features of autism spectrum disorders. These disorders are characterized by impaired communication and socialization skills, as well as delayed development of speech and language. In 16p11.2 deletion syndrome, expressive language skills (vocabulary and the production of speech) are generally more severely affected than receptive language skills (the ability to understand speech). Some people with this disorder have recurrent seizures (epilepsy).

Some affected individuals have minor physical abnormalities such as low-set ears or partially webbed toes (partial syndactyly). People with this disorder are also at increased risk of obesity compared with the general population. However, there is no particular pattern of physical abnormalities that characterizes 16p11.2 deletion syndrome. Signs and symptoms of the disorder vary even among affected members of the same family. Some people with the deletion have no identified physical, intellectual, or behavioral abnormalities.

Most people tested for the 16p11.2 deletion have come to medical attention as a result of developmental delay or autistic characteristics. Other individuals with the 16p11.2 deletion have no associated health or behavioral problems, and so the deletion may never be detected. For this reason, the prevalence of this deletion in the general population is difficult to determine but has been estimated at approximately 3 in 10,000.

Other Names for This Condition

  • Autism, susceptibility to, 14A
  • AUTS14A

Causes & Risk Factors

People with 16p11.2 deletion syndrome are missing a sequence of about 600,000 DNA building blocks (base pairs), also written as 600 kilobases (kb), at position p11.2 on chromosome 16. This microdeletion affects one of the two copies of chromosome 16 in each cell. The 600 kb region contains more than 25 genes, and in many cases little is known about their function. Researchers are working to determine how the missing genes contribute to the features of 16p11.2 deletion syndrome.

Inheritance

16p11.2 deletion syndrome is considered to have an autosomal dominant pattern because a deletion in one copy of chromosome 16 in each cell is sufficient to cause the condition. However, most cases of 16p11.2 deletion syndrome are de novo. The deletion occurs most often as a random event during the formation of reproductive cells (eggs and sperm) or in early fetal development. Affected people typically have no history of the disorder in their family, although they can pass the condition to their children. Several examples of inherited 16p11.2 deletion have been reported. In inherited cases, other family members may be affected as well.

Frequently Asked Questions

Watch for delayed eye contact, limited use of gestures, reduced babbling before 12 months, and lack of response to name. If a child shows fewer than 10 words by 18 months or has difficulty sharing interest, a developmental pediatrician or early intervention specialist should be consulted for a comprehensive evaluation. How does the 16p11.2 deletion influence seizure risk, and what monitoring or preventive strategies should families consider?::Seizures occur in about 10–20% of individuals with this deletion. Families should monitor for sudden loss of consciousness, staring spells, or unusual movements. If seizures are suspected, an EEG and neurologic evaluation are recommended. Early seizure control with antiepileptic medication can reduce developmental impact. What dietary or lifestyle approaches can help manage the increased risk of obesity associated with 16p11.2 deletion?::Regular physical activity tailored to the child's abilities, limiting sugary drinks, and monitoring portion sizes are foundational. A dietitian can design a balanced meal plan that includes whole grains, lean proteins, and plenty of fruits and vegetables. Tracking weight and BMI percentile every 3–6 months helps adjust interventions early. Are there specific therapies or interventions that have shown benefit for language or social skills in this population?::Early speech‑language therapy focusing on expressive language, combined with social skills groups or play therapy, can improve communication. Applied Behavior Analysis (ABA) techniques may also help with social interaction and reducing repetitive behaviors. Consistent, structured routines and visual schedules support learning and reduce anxiety.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab